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Abstract
Inhibition of protein synthesis occurs in the post-ischemic reperfused kidney but the molecular mechanism of renal translation arrest is
unknown. Several pathways have been identified whereby cell stress inhibits translation initiation via phosphorylation of the alpha subunit of
eukaryotic initiation factor 2 (eIF2a, phospho-form eIF2a(P)]. Here, we report a 20-fold increase in eIF2a(P) in kidney homogenates
following 10 min of cardiac arrest-induced ischemia and 10 min reperfusion. Using immunohistochemistry, we observed eIF2a(P) in tubular
epithelial cells in both cortex and medulla, where the greatest eIF2a(P) staining was found in epithelial cells of the so-called watershed area at
the corticomedullary junction. We further show that increased eIF2a(P) is accompanied by activation of the PKR-like endoplasmic reticulum
eIF2a kinase (PERK). These observations indicate that renal ischemia and reperfusion induce stress to the endoplasmic reticulum and
activate the unfolded protein response in renal epithelial cells. As the unfolded protein response can result alternatively in a pro-survival or
pro-apoptotic outcome, the present study demonstrates an new additional mechanism involved in cell damage and/or repair in ischemic and
reperfused kidney.
D 2005 Elsevier B.V. All rights reserved.
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1. Introduction
Renal ischemia and reperfusion (I/R) result in signifi-
cant mortality and morbidity in a variety of clinical
contexts [1,2]. However, in spite of a number of identified
damage mechanisms, including deleterious inflammatory
responses [3,4], endothelial dysfunction [5], nitric oxide
dysregulation and oxidative stress [6–8], and caspase
activation [9], the understanding of renal injury following
I/R is still incomplete.
Depression of protein synthesis is characteristic of
reperfused kidney [10]. Plestina and Gamulin [11] showed
that renal I/R results in polysome disaggregation, which is
indicative of inhibited translation initiation [12]. However,
the mechanism of translation initiation inhibition in post-
ischemic kidney is unknown. A variety of stresses cause
translation initiation inhibition, including heme depletion
[13], viral infection [14], stress to the endoplasmic reticulum
[15], and amino acid depletion [16]. Each of these stresses
activates specific regulatory pathways leading to the
phosphorylation of the alpha subunit of eukaryotic initiation
factor 2 [eIF2; alpha subunit, eIF2a; alpha subunit phospho-
form, eIF2a(P)].
Under conditions of active protein synthesis, the function
of eIF2 is to deliver the first amino acid, which is always a
methionine in eukaryotes, to the 40S ribosomal subunit
during the process of translation initiation [12]. To do so,
eIF2 requires binding of GTP. At the end of translation
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initiation, the GTP bound to eIF2 is hydrolyzed to GDP and
the eIF2–GDP complex is functionally inactive. Therefore,
a second initiation factor, eIF2B, exchanges the GDP bound
to eIF2 with GTP, thereby recycling eIF2 for another round
of translation initiation. When the alpha subunit of eIF2 is
phosphorylated, this increases the binding affinity between
eIF2B and eIF2(aP) by 150-fold [17]. Thus, eIF2(aP)
effectively removes eIF2B from the catalytic cycle, and
allows the accumulation of inactive eIF2–GDP, which halts
translation initiation and leads to polysome disaggregation.
Further, the typical stoichiometry of eIF2 to eIF2B is 5:1
[18], so that phosphorylation of only 20% of total eIF2 can
sequester essentially all eIF2B, leading to complete trans-
lation arrest.
A well-studied example of clinically relevant protein
synthesis inhibition is that which occurs in the brain
following I/R. Here, it has been shown that protein synthesis
inhibition is also due to inhibited translation initiation which
is caused by a massive and rapid increase in phosphor-
ylation of eIF2a at the onset of reperfusion ([19], reviewed
in [20]). Further, eIF2a phosphorylation in reperfused brain
is due to activation of the endoplasmic reticulum (ER)
eIF2a kinase PERK [25]. PERK is activated as part of the
unfolded protein response (UPR), an endoplasmic reticulum
(ER) stress system (reviewed in [21]).
We reasoned that the cellular stress response would be
conserved between brain and kidney following I/R and so
we undertook studies of eIF2a phosphorylation and PERK
activation in ischemic and reperfused kidney. We show here
that this response is indeed conserved and report an
approximately 20-fold increase in eIF2a(P) in reperfused
kidney, concurrent with PERK activation. Further, immu-
nohistochemical mapping localized eIF2a(P) to tubular
epithelial cells, indicating that these cells experience ER
stress during renal I/R. Our observations provide further
insight into the cellular response of renal tubular epithelium
to ischemic injury.
2. Materials and methods
Polyclonal anti-PERK antiserum was a gift from David
Ron (New York University, NY) and has been previously
described [22]. Phospho-specific PERK antisera [PERK(P)]
was purchased from Cell Signaling Technology, Inc.
(Beverly, MA, U.S.A.) and detects PERK phosphorylation
at Thr980. Antibodies specific for total eIF2a or specific for
the serine-51 phosphorylated form of eIF2a [eIF2a(P)]
were purchased from Biosource International (Cammarillo,
CA, U.S.A.). All other chemicals were reagent grade.
2.1. Ischemia protocol
All animal experiments were approved by the Wayne
State University Animal Investigation Committee and were
conducted following the Guide for the Care and Use of
Laboratory Animals (National Research Council, revised
1996).
The thoracic compression method of cardiac arrest was
used to induce whole-body ischemia in male Long Evans
rats (250–300 g) (Harlan, Indianapolis, IN) by methods we
have previously described [23,24]. Briefly, male Long
Evans rats weighing 250–300 g were anesthetized with
intraperitoneal ketamine (45 mg/kg) and xylazine (5 mg/kg).
Femoral vascular access was established for arterial pressure
monitoring and intravenous fluid and drug administration.
All animals were maintained normothermic (37T0.5 -C)
during both the ischemic and reperfusion periods by means
of a homeostatic blanket control unit (Harvard Apparatus,
Holliston, MA). The electrocardiogram was monitored by
limb leads. A tracheostomy was performed on the rats with a
14-gauge angiocath for positive pressure mechanical ven-
tilation. Immediately after instrumentation, cardiac arrest
was initiated by thoracic compression, causing circulatory
arrest within 5 s. Following a 10-min duration of cardiac
arrest, mechanical ventilation began, and manual chest
compressions was delivered at a rate of 200–300 per
minute, until establishment of return of spontaneous
circulation (average time 94T21 s). Reperfusion was
defined as a sustained mean arterial pressure>60 mm Hg.
Mechanical ventilation was with 100% O2 at 70 breaths per
minute, a tidal volume of 1.0 ml/100 g body weight and
positive end expiratory pressure of 3 cm H2O. Mechanical
ventilation was provided for the entire reperfusion duration.
Experimental groups (n =3 per group) were: nonischemic
controls (NIC), 5 min ischemia only (5I), 10 min ischemia
only (10I), 5 min ischemia and 10 min reperfusion (5I/10R),
10 min ischemia and 10 min reperfusion (10I/10R), and 10
min ischemia and 90 min reperfusion (10I/90R).
2.2. Renal tissue preparation and immunoprecipitation
At the indicated ischemia or reperfusion times, animals
were decapitated, placed on ice, and kidneys were imme-
diately dissected bilaterally. For some experiments, renal
cortex was dissected from the renal medulla. Tissue was
kept on ice, minced and then homogenized in a ground glass
mechanical homogenizer until liquified. Homogenization
buffer consisted of 20 mM HEPES pH 7.5, 10% glycerol, 1
mM EDTA, 10 mM tetrasodium pyrophosphate, 100 mM
NaF, 17.5 mM h-glycerophosphate, 1:42 dilution of Sigma
protease inhibitor cocktail (P8340), 5 AM okadaic acid, and
0.04% trypsin inhibitor. Unfractionated homogenate protein
concentrations were determined by the Folin phenol reagent
method, and homogenates were stored at 80 -C until used.
Total PERK or PERK(P) were detected using antisera for
total PERK or PERK(P), respectively, by first immunopre-
cipitating and then detecting immunoprecipitates by West-
ern blot. The immunoprecipitation (IP) protocol was as
previously described [25]. For both PERK and PERK(P)
immunoprecipitations, 30 mg homogenate protein was used
per IP reaction.
H.L. Montie et al. / Biochimica et Biophysica Acta 1741 (2005) 314–324 315
For eIF2a(P) Western blots, 125 Ag protein from
unfractionated homogenates was run per lane on SDS-
PAGE, and electroblot transferred to nitrocellulose as
previously described [23]. For Western blotting, primary
antisera dilutions were: eIF2a(P), 1:750; PERK(P), 1:2000;
PERK, 1:10,000. Quantitation of Western blots was by
densitometric analysis (Bio Image Intelligent Quantifier,
version 3.1). Groups were compared by analysis of variance
and LSD post hoc with significance set at P <0.05.
2.3. Immunocytochemistry and light microscopy
Localization of eIF2a(P) in rat kidney using immuno-
histochemistry was done on kidneys fixed by retrograde
perfusion via the aorta with 2% paraformaldehyde in 0.1 M
phosphate buffered saline, pH 7.4. Kidneys were dehydrated
using an alcohol series and embedded in paraffin. Sagittal
sections (4 Am) of whole kidney were stained with
hematoxylin. For immunoperoxidase labeling, endogenous
peroxidase was blocked by 3% H2O2 in absolute methanol
for 10 min at room temperature. To reveal antigens, section
were put through a 1-mM sodium citrate solution at pH 6.0
at 95 -C for 20 min. Nonspecific binding of immunoglo-
bulin was prevented by blocking in PBS supplemented with
1% horse serum for 10 min. Sections were incubated
overnight for 18 h at 4 -C with primary antibody to
eIF2a(P) diluted (1:100) in PBS. Sections were washed
three times with PBS, then incubated with a biotinylated
secondary antibody for 10 min (anti rabbit Ig Vectastain kit
[Vector, Inc.]), followed by horseradish peroxidase-conju-
gated streptavidin for 10 min. Sections were incubated with
aminoethyl carbazole (AGC) chromogen and development
of immunostaining was monitored microscopically. The
microscopy was carried out using the Axioplan 2 Imaging
System (Carl Zeiss, Oberkochen, Germany). Digital images
were acquired with the AxioCam MRm high resolution
digital camera.
2.4. Creatinine assessment
Trunk blood was obtained from each rat at the time of
sacrifice and placed into heparinized tubes. Plasma crea-
tinine was measured in duplicate using a creatinine assay kit
based on a modification of the Jaffe reaction (Cayman
Chemicals, Ann Arbor, MI).
3. Results
In homogenates of unfractionated whole kidney, eIF2-
a(P) levels increased during reperfusion in proportion to the
ischemic duration. Five minutes of ischemia followed by 10
min reperfusion lead to a 7-fold increase in whole kidney
eIF2a(P) (ANOVA P=0.048), whereas 10 min ischemia
and 10 min reperfusion resulted in a 20-fold increase in
eIF2a(P) (ANOVA P <0.001). Total levels of eIF2a were
unchanged (ANOVA P=0.43) (Fig. 1). There was no
increase in eIF2a(P) (ANOVA P=0.28) nor change in the
level of eIF2a (ANOVA P=0.37) in kidneys after either 5
or 10 min ischemia only (Fig. 2). To determine if the
eIF2a(P) increase was selective for renal cortex or medulla,
these were dissected and assessed separately for eIF2a and
Fig. 1. Levels and phosphorylation of eIF2a as assessed by Western blot of 125 Ag homogenate protein per lane in unfractionated homogenates of whole
kidney in nonischemic controls (NIC), following 5 min ischemia and 10 min reperfusion (5I/10R), and following 10 min ischemia and 10 min reperfusion (10I/
10R). At a constant reperfusion time of 10 min, phosphorylation of eIF2a increased as a function of ischemic duration. Thapsigargin treated (tg+) NB104 cells
provides a positive mobility control for eIF2a(P). Bar graph shows meanT standard deviation. Values are normalized such that NIC average is 100%. *P <0.05
compared to NIC group.
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eIF2a(P) (Fig. 3). At 10 min ischemia and 10 min
reperfusion, eIF2a(P) increased approximately 8-fold in
both cortex and medulla (Fig. 3, ANOVA P <0.05). The 16-
fold increase in eIF2a(P) that results from adding cortical
and medullary eIF2a(P) was statistically indistinguishable
from the 20-fold eIF2a(P) increase obtained in whole
kidney (two-tailed t-test, P=0.12). At 90-min reperfusion
following 10 min ischemia, eIF2a(P) returned to control
levels in both cortex and medulla. There was no change in
total eIF2a in cortex (ANOVA P=0.33) or medulla
(ANOVA P=0.28) (Fig. 3). We note that endogenous
eIF2a(P) levels in NIC kidney were higher than in the
untreated NB104 cells. Even compared to NIC brain
samples, endogenous renal eIF2a(P) levels were higher
Fig. 2. Levels and phosphorylation of eIF2a as assessed by Western blot of 125 Ag homogenate protein per lane in unfractionated homogenates of whole
kidney in nonischemic controls (NIC), or following 5 min (5I) or 10 min (10I) of cardiac arrest-induced ischemia. There was no change in eIF2a levels or
eIF2a(P) phosphorylation in the ischemic period. Thapsigargin treated (tg+) NB104 cells provides a positive mobility control for eIF2a(P). Bar graph shows
meanT standard deviation of scanning densitometry. Values are normalized such that NIC average is 100%.
Fig. 3. Levels and phosphorylation of eIF2a in cortical and medullary homogenates. Following 10 min ischemia and 10 min reperfusion (10I/10R), eIF2a(P)
levels in cortex and medulla were equal and were ~8-fold those of nonischemic controls (NIC). By 90 min reperfusion following 10 min ischemia (10I/90R),
eIF2a(P) levels had returned to control levels. There was no change in total eIF2a. Bar graph shows meanT standard deviation. Values are normalized such that
NIC average is 100%. *P <0.05 compared to NIC group.
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(data not shown). We also note that apparent disparities in
the NIC levels of eIF2a(P) among Figs. 1–3 are due to
different film exposure conditions. Because the increase in
eIF2a(P) is so high in reperfused samples, Western blots
containing reperfused samples required specific exposure
conditions to be able to visualize all three groups adequately
on the same film development while maintaining linearity
for densitometric analysis.
To determine the cause of eIF2a phosphorylation, the
activation status of PERK was assessed following immu-
noprecipitation and detection by Western blot. Activation
of PERK is accompanied by its autophosphorylation,
causing PERK to migrate slower on SDS-PAGE gels
[22,25]. Immunoprecipitation with an antisera that recog-
nizes both the phosphorylated and unphosphorylated forms
of PERK showed increased PERK(P) following ischemia
and reperfusion (Fig. 4). In nonischemic control (NIC)
kidneys, 27% of PERK was in the phosphorylated, active
form (Table 1). At 5I/10R, 65% of PERK was in the active,
phosphorylated form, and this decreased slightly to about
60% in the 10I/10R and 10I/90R groups (Table 1). Thus,
following reperfusion, the majority of PERK is in the
active state. We note that inactive renal PERK migrated
slightly below the inactive PERK band from the NB104
cells (Fig. 4), and this is consistent with a previous study
showing that inactive renal PERK migrated below inactive
PERK from other tissues [26]. Total PERK [PERK+
PERK(P)] was observed to be significantly decreased at 90
min reperfusion to roughly 10% of control levels. To
further confirm PERK activation, immunoprecipitation was
also performed with an antisera specific only for PERK(P)
(Fig. 5). In the 10I/10R group, multiple bands, correspond-
ing to the different phospho-forms of PERK were detect.
As PERK has been shown to contain 11 authentic
phosphorylation sites [27], the presence of multiple
PERK(P) bands in not unexpected. The 10I/10R and 10I/
90R groups showed 10-fold and 2-fold increases in
PERK(P), respectively, over the other experimental groups
(Fig. 4C, ANOVA P <0.05).
We next ascertained which renal cells contained eIF2a(P)
by immunohistochemistry. As a control for eIF2a(P)
Fig. 4. PERK is activated by renal ischemia and reperfusion. Following immunoprecipitation with PERK antisera and detection by Western blot with the same
antisera, active, hyperphosphorylated PERK migrates slower than inactive PERK on SDS-PAGE and is therefore identified by its decreased mobility.
Neuroblastoma cells were either treated (tg+) or not treated (tg) with thapsigargin, an agent that causes stress to the endoplasmic reticulum and PERK
activation, providing mobility controls for active [PERK(P)] and inactive PERK. Note the inactive renal PERK migrates slightly below inactive PERK from
NB104 cells, as shown in Harding et al. [26]. Scanning densitometry shows a shift from predominantly inactive PERK in the nonischemic (NIC) group to
predominantly active PERK after 5 min ischemia and 10 min reperfusion (5I/10R), 10 min ischemia and 10 min reperfusion (10I/10R), and 10 min ischemia
and 90 min reperfusion (10I/90R) (* P <0.05 compared to NIC group for levels of PERK(P)). There is also an absolute loss of PERK in the 10I/90R group (and
P <0.05 for total levels of PERK [PERK+PERK(P)]). Bar graph shows meanT standard deviation of densitometry. These data are summarized numerically in
Table 1.
Table 1
Montie et al., renal ischemia and PERK activation
NIC 5I/10R 10I/10R 10I/90R
PERK(P) 27T11% 65T13%* 61T5%* 60T4%*
PERK 73T11% 35T13% 39T5% 40T4%
Relative levels 1T0.8 1T0.9 2T1.3 0.1T0.07*
Percentages of inactive PERK and phosphorylated PERK [PERK(P)], and
relative levels of total PERK [PERK+PERK(P)] following ischemia and
reperfusion determined from scanning densitometry of total PERK IP as
shown in Fig. 4. Shown are the percentages of PERK in the inactive and
active forms such that the totals add to 100%. The bottom row shows the
relative levels of total PERK. Abbreviations as in Figs. 1 and 3.
* Post hoc P <0.05 compared to NIC group.
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staining, immunohistochemistry was also performed on
cerebellum from NIC and 10I/10R animals, in which we
previously showed undetectable eIF2a(P) in NICs, and
intense eIF2a(P) staining in reperfused cerebellar neurons
[28,29]. As shown in Fig. 6A and B, our previous results in
cerebellum were confirmed. Further, Western blots for
eIF2a(P) in unfractionated kidney homogenates showed
only a single band migrating at 35 kDa, indicating the
monospecificity of the eIF2a(P) antisera in kidney and its
suitability for immunohistochemical analysis.
Fig. 5. Immunoprecipitation followed by Western blot with antisera against phosphorylated PERK [PERK(P)] gave the largest signal in the 10I/10R group. At
least two different phospho-forms of PERK were detected at 10R and 90R. Scanning densitometry shows a 10-fold increase in PERK(P) in the 10I/10R group
and a 2-fold increase in the 10I/90R group, compared to nonischemic controls (NIC) and 5 min ischemia and 10 min reperfusion.
Fig. 6. Immunoperoxidase staining of eIF2a(P) using paraffin-embedded tissues from (A, C) nonischemic rat cerebellum (40) and kidney (10) and (B, D)
10 min ischemia/10 min reperfusion (10I/10R) rat cerebellum and kidney. Immunolabeling of eIF2a(P) is associated with Purkinje and granular cells of the
cerebellum and prominently at the corticomedullary junction of the kidney (arrow) as well as superficial cortical areas (arrowhead).
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Low magnification views of eIF2a(P) staining
showed no signal in NICs (Fig. 6C). However, follow-
ing 10 min ischemia and 10 min reperfusion, a
prominent band of eIF2a(P) staining was observed at
the corticomedullary junction (Fig. 6D). Staining was
also evident along the most superficial cortex. At low
magnification, the 10I/90R group resembled controls
(data not shown).
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At high magnification (20 objective) no eIF2a(P) was
detectable in NIC cortex (CTX), corticomedullary junction
(CMJ), or medulla (MED) (Fig. 7A–C). At 10I/10R, most
glomerular cells showed no eIF2a(P). However, some cells
within the glomerulus, putatively identified as inflammatory
cells on the basis of their morphology, showed intense
eIF2a(P) staining around the nucleus (Fig. 7D, arrow). The
majority of cortical eIF2a(P) staining was observed in tubular
epithelial cells, notably the proximal cortical tubule (7D,
arrowheads). Faint staining of distal tubule segments was also
present. The strongest eIF2a(P) staining was obtained in
proximal tubule cells at the corticomedullary junction (Fig.
7E). Dilated and congested capillaries were visible within the
medulla (7F, arrow) at 10I/10R, as well as staining of some
tubular epithelial cells and inflammatory cells. By 90 min
reperfusion, eIF2a(P) staining abated significantly, although
faint residual staining was observed in cortex, corticomedul-
lary junction and medullary epithelial cells (Fig. 7G–I). Cells
positive for eIF2a(P) were evident within the tubular lumen
(Fig. 7H, arrowhead and inset). Capillary congestion (Fig. 7I,
arrowhead) and casts (Fig. 7I, arrow) were present within the
inner medulla. Thus, eIF2a(P), and by extension, eIF2a
kinase activity, is largely confined to the tubular epithelial
cells of the nephron, and is greatest in the poorly vascularized
‘‘watershed’’ area at the corticomedullary junction.
Since there were no significant differences in plasma
creatinine between the 10I/10R and 10I/90R groups, these
values were grouped together. Despite the relatively brief
period of whole body ischemia, plasma creatinine was
significantly higher in the ischemic group (Fig. 8).
4. Discussion
The novel findings of the present study are that, following
a clinically relevant 10 min duration of cardiac arrest,
eIF2a(P) greatly increased and PERK was activated in renal
tubular epithelial cells, providing a cellular mechanism for
the inhibition of protein synthesis that occurs in kidney
following I/R [10]. Further, these changes co-occurred with
morphological and physiological evidence of renal ischemic
damage (Figs. 7 and 8). Activation of PERK is a marker of
ER stress and activation of the unfolded protein response
(UPR) [15]. Although these mechanisms have been thor-
oughly investigated in brain (as reviewed in 20), demon-
strating their occurrence in reperfused kidney is novel for the
following reasons. First, our results show conservation of the
ER stress response in reperfused kidney and brain. Given the
extreme sensitivity of brain to ischemic injury as compared
to kidney, it is not an a priori given that both organs would
respond similarly to I/R. Second, the present results have
implications for the treatment of pathologies associated with
renal I/R, such as renal transplantation surgery, shock, or
following resuscitation from cardiac arrest. As elaborated
below, ER stress and the UPR may play a causal role in renal
dysfunction and recovery following I/R.
In the present study, we did not measure protein synthesis
as its depression following renal reperfusion is well known
(reviewed in 10). Instead, our aim here was to investigate a
well-established pathway of translation arrest to provide
deeper insight into the renal cellular response to I/R.
Plestina and Garmulin [11] showed a 16% decrease in
polysomes in mouse kidney following 5 min ischemia
alone, and a 36% decrease in polysomes with reperfusion
durations out to 6 h. Further, these authors showed that
administration of cycloheximide, an elongation inhibitor,
prevented ischemic-, but not reperfusion-induced polysome
disaggregation. Our results, in conjunction with this
previous study, indicate that multiple mechanisms underlie
renal translation arrest following I/R.
In kidney after 10 min ischemia induced by renal pedicle
ligation, ATP levels fell to roughly 12% of control values
and energy charge was 7% of controls [30]. Thus, during
ischemia, polysome disaggregation could be due to run off
of existing polysomes and decreased rate of translation
initiation due to depletion of ATP. This would explain the
ability of cycloheximide to prevent polysome disaggrega-
tion during ischemia, by ‘‘freezing’’ polysomes and pre-
venting run-off, and is consistent with our demonstration of
Fig. 7. Immunoperoxidase staining of eIF2a(P) in renal cortex (CTX), corticomedullary junction (CMJ) and medulla (MED) at 20 magnification. (A–C)
Nonischemic kidney (NIC) showing no detectable immunolabeling for eIF2a(P) at any level. (D–F) After 10 min ischemia and 10 min reperfusion (10I/10R),
glomeruli were largely free of immunolabeled eIF2a(P), however, some cells (consistent with inflammatory cells) within the glomerulus showed intense
eIF2a(P) staining around the nucleus (D, arrow). Strong immunoreactivity for eIF2a(P) staining in tubular epithelial cells, especially proximal tubules (D,
arrowheads). Faint staining of distal tubule segments was also present. The strongest eIF2a(P) staining was obtained in proximal tubule cells at the
corticomedullary junction (E). Dilated and congested capillaries were visible within the medulla (F, arrow) as well as staining of tubular epithelial cells lining
the lumen or shed into the lumen (arrowheads). (G– I) Following 90 min reperfusion, faint residual staining for eIF2a(P) staining in cortex, corticomedullary
junction and medullary epithelial cells. Cellular debris (G, arrow) and epithelial cells positive for eIF2a(P) (H, arrowhead and inset) were evident within the
tubular lumen. Capillary congestion (I, arrowhead) and casts within the tubular lumen (I, arrow) were present within the medulla.
Fig. 8. Plasma creatinine values in nonischemic (NIC) and ischemia+
reperfusion (I/R) groups. The I/R group consists of the pooled values from
the 10I/10R and 10I/90R groups. Values are mean TSE (n =6 per group,
*P <0.02 vs. NIC).
H.L. Montie et al. / Biochimica et Biophysica Acta 1741 (2005) 314–324 321
lack of eIF2a(P) increase during ischemia only. Upon
reperfusion, renal ATP returns [30], and eIF2a(P) rapidly
increases, which could account for the cycloheximide-
refractory disaggregation of polysomes observed by Plestina
and Garmulin [11]. However, we observed eIF2a(P) to
return to control levels by 90 min reperfusion. Thus,
polysome disaggregation outlasts eIF2a phosphorylation.
In fact, this is similar to the situation observed in brain in
which protein synthesis inhibition and polysome disaggre-
gation outlast eIF2a phosphorylation [31]. Thus, in both
brain and kidney, a mechanisms of translation inhibition
other than eIF2a phosphorylation must occur following
longer reperfusion durations. What this mechanism might be
is currently unknown (reviewed in [20]).
In addition to providing insight into the mechanisms of
translation arrest following renal I/R, our observations
indicate the cellular context within which eIF2a(P)-mediated
translation arrest occurs. The evidence for PERK activation
shown above (Figs. 4 and 5) is definitive molecular evidence
for UPR activation and hence indicates that renal epithelial
cells experience ER stress following I/R.
We note that in the 5I/10R group, following total PERK
IP (Fig. 4), we observed 65% of total PERK (Table 1) to be
in slower migrating, phosphorylated forms. However,
following PERK IP using antisera specific for PERK
phosphorylated at threonine 980 [PERK(ThrP980)], we
observed no increase at 5I/10R compared to controls (Fig.
5). Generally, multiple forms of PERK(P) were observed in
kidney following I/R (Fig. 5, 10I/10R group) which is not
unexpected as PERK has been shown to possess 11
authentic phosphorylation sites [27]. The functional signifi-
cance of these phospho-forms, and particularly their role in
PERK activation, remains to be investigated. Therefore, one
possibility for our result is that PERK(ThrP980) is not an
absolute requirement of PERK activation, and the increase
in PERK(P) shown in Fig. 4 is more indicative of PERK
activation. A second possibility is that PERK(ThrP980) is
an absolute indicator of PERK activation, and PERK was
not activated in the 5I/10R group. This possibility would
indicate that regulation of eIF2a(P) following renal ische-
mia is more complex and involves multiple eIF2a kinases.
Further studies will be required to distinguish between these
two possibilities.
We also observed an absolute loss of PERK at 90 min
renal reperfusion, which also occurs following 90 min brain
reperfusion [24]. The significance of PERK loss following
its reperfusion-induced activation is not currently under-
stood. We note that the inactive form of renal PERK
migrated slightly below that from the NB104 cells. The
smaller form of inactive renal PERK has been previously
reported [26], although, to our knowledge, its significance
has not been investigated.
Unlike brain [24], the eIF2a phosphorylation we
observed in reperfused kidney is reversible within 90 min
following a 10 min ischemic insult (Fig. 3). Although at
90R the remaining PERK was predominantly in the active
form, the overall loss of PERK would be expected to lead to
a net increase in eIF2a(P) phosphatase activity, and may
account for the rapid dephosphorylation of eIF2a(P) by
90R. The present model, based on clinically relevant
durations of cardiac arrest and resuscitation, has been used
extensively to study brain I/R but precludes longer durations
of ischemia (20–30 min) typical of renal ischemia studies.
We have shown here proof of principle that renal I/R
activates PERK. Although requiring further investigation,
our observation of PERK activation implies activation of the
UPR following renal I/R. Since eIF2a(P) increased as a
function of ischemic duration (Fig. 2), it may be expected
that longer durations of ischemia will cause a more intense
ER stress and sustained UPR activation.
The present study shows clearly that the translation
inhibition function of the UPR is activated in kidney
following I/R. Other studies have also provided evidence
suggesting UPR activation following in vivo renal ischemia
or in cultured tubular cells. Kuznetsov et al. observed
upregulation of the mRNAs for ER localized proteins
GRP78, GRP94, and ERP72 following 30-min acute renal
ischemia [32]. Treatment of Madin–Darby canine kidney
cells with the ER stress inducers tunicamycin and A23187
resulted in significant cytoprotection after subsequent ATP
depletion, suggesting activation of the UPR [33]. In a
culture system of simulated ischemia, proteomic analysis of
LLC-PK1 cells showed upregulation of GRP78, along with
heat shock proteins [34].
UPR activation may be an additional important mecha-
nism whereby renal I/R injury leads to differential suscept-
ibility of tubular epithelial segments via either a pro-survival
or pro-apoptotic phenotype in affected cells. The observed
increase in eIF2a(P) immunohistochemical staining of
tubular segments at the poorly vascularized corticomedul-
lary junction (Fig. 6D, arrow) is consistent with the
increased ischemic susceptibility in this region. This highly
localized increase in eIF2a(P) may contribute to the greater
cellular damage typically seen in cells of the S3 segment of
the proximal tubule and outer medullary thick ascending
limb in renal ischemic injury. The eIF2a(P) distribution also
explains the relatively equal content of eIF2a(P) in cortical
and medullary homogenates (Fig. 3), as our dissection likely
split the corticomedullary junction equally between dis-
sected regions.
The significance of UPR-mediated renal apoptosis has
been discussed with respect to tunicamycin-treated CHOP
knockout mice that undergo acute tubular necrosis [35].
CHOP knockout mice showed attenuated renal apoptosis
compared to wild types, and slower recovery of renal
function. Zinszner et al. proposed that CHOP-mediated cell
death may actually be beneficial by promoting the regen-
eration of epithelium through removal of damaged tubular
cells [35]. Thus, UPR expression in reperfused kidney may
serve a dual role. Renal tubular epithelial cells subjected to
severe ER stress and more intense activation of UPR due to
the duration or magnitude of the ischemic insult, nature of
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the microcirculation, and/or intrinsic cellular susceptibility
will experience apoptotic cell death and removal. Less
intensely affected renal tubular cells may undergo UPR-
associated transient inhibition of protein synthesis followed
by an increase in the processing capacity of the ER with
recovery of cell function. Together with activation of the
heat shock proteins [36,37], the UPR may contribute to
tubular epithelial cells regaining their cytoskeletal architec-
ture and polarity, while others may enter the cell cycle and
mitosis resulting in repopulation of lost renal tubular cells.
In contrast to its role in the brain, the pro-apoptotic
expression of the UPR may therefore serve to complement
its pro-survival role in the reperfused kidney.
In conclusion, the present study demonstrated activation
of PERK and phosphorylation of eIF2a, indicating ER stress
and activation of the UPR, following renal I/R. These
findings open the door to ascertaining the significance of
ER stress and UPR expression in post-ischemic reperfused
kidney. Future studies are needed to assess the status of IRE1
and ATF6, as well as other downstream UPR components in
reperfused kidney. The ultimate aim of such investigations
will be to determine the relative contributions of pro-survival
or pro-apoptotic UPR pathways to renal dysfunction and
recovery following I/R. Given the importance of ER-
localized protein synthesis for renal tubular function, such
as the absolute requirement for synthesis of transmembrane
transport proteins, and the unique exposure of the kidney to a
variety of substances with potential to stress the ER, it is
expected that the results presented here may be generalizable
to other forms of clinically relevant renal damage.
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